Current Edition

news

Trade Idea: Biopharmaceutical Endocyte Hits 4-Year High on Earnings

ECYT lives squarely in small-cap territory. And that’1018s not a bad thing in 2018. On a year-to-date basis, the small-cap focused Russell 2000 Index has …

Continue Reading →